News und Analysen
Groupon Issues Second Quarter Earnings Release
Groupon (NASDAQ:GRPN) issued its second quarter earnings press release today and announced a plan to lower annual expenses and outlined progress on the company’s turnaround strategy.
The second
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR)
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR)
Investors Title Company Declares Quarterly Dividend
Investors Title Company (Nasdaq: ITIC) announced today that the Company's Board of Directors has declared a cash dividend of $.46 per share to shareholders of record September 1, 2022, payable
AIG Reports Second Quarter 2022 Results
American International Group, Inc. (NYSE: AIG) today reported financial results for the second quarter ended June 30, 2022.
AIG Chairman & Chief Executive Officer Peter Zaffino said: “AIG had
IFF Reports Second Quarter 2022 Results
International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the second quarter ended June 30, 2022.
Second Quarter 2022 Consolidated Summary:
Reported
(GAAP)
Inseego Reports Second Quarter 2022 Financial Results
Inseego Corp. (Nasdaq: INSG) (the “Company”), a leader in 5G edge cloud solutions, today reported its results for the second quarter ended June 30, 2022. The Company reported second quarter net
ICMI’s Contact Center Expo Unveils Contact Center Tours at Four Innovative Contact Centers in Orlando
ICMI’s Contact Center Expo, taking place October 24-27 at the Omni Orlando Resort at Championsgate in Orlando, Florida, today announces four contact center tours at innovative contact centers in
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Clovis Oncology Announces Second Quarter 2022 Operating Results and Provides Update on Clinical Development Programs
Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended June 30, 2022, and provided an update on the Company’s clinical development programs and regulatory and
Flexsteel Industries, Inc. to Announce Fourth Quarter 2022 Results on Monday, August 22
Flexsteel Industries, Inc. (NASDAQ:FLXS) (“Flexsteel” or the “Company”), one of the largest manufacturers, importers and online marketers of furniture products in the United States, announced today
Nordson Corporation Announces Agreement to Acquire CyberOptics Corporation, Expanding Its Semiconductor Test and Inspection Capabilities
Nordson Corporation (Nasdaq: NDSN) has signed a definitive agreement for the acquisition of CyberOptics Corporation (Nasdaq: CYBE), a leading global developer and manufacturer of high-precision 3D
1-800-FLOWERS.COM, Inc. to Release Results for its Fiscal 2022 Fourth Quarter and Full Year on Thursday, September 1, 2022
1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS), a leading provider of gifts designed to help inspire customers to give more, connect more, and build more and better relationships, today announced that the
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Pfizer Inc. (NYSE: PFE) and Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a
Aroundtown SA: Release of a capital market information
Poxel Announces Extended Cash Runway with Debt Restructuring Agreement and Equity-linked Financing Facility
POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including
Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2022
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on August 3, 2022, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement
T-Mobile Secures First-Ever Full Investment Grade Rating
T-Mobile US, Inc. (NASDAQ: TMUS) today announced that following an investment grade issuer rating from S&P Global Ratings (S&P) – the third it has received from credit rating agencies – the company
T-Mobile Secures First-Ever Full Investment Grade Rating
T-Mobile US, Inc. (NASDAQ: TMUS) today announced that following an investment grade issuer rating from S&P Global Ratings (S&P) – the third it has received from credit rating agencies – the company
T-Mobile Secures First-Ever Full Investment Grade Rating
T-Mobile US, Inc. (NASDAQ: TMUS) today announced that following an investment grade issuer rating from S&P Global Ratings (S&P) – the third it has received from credit rating agencies – the company
Kohl’s Partners with the Buffalo David Bitton Brand to Introduce Premium Denim for Customers
Today, Kohl’s (NYSE: KSS) has announced a new partnership with Buffalo David Bitton, which is owned by Iconix International, to bring premium and responsibly-made denim styles to customers just in